Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters ...

Find insight on Novo Nordisk, Praram 9 Hospital, European exporters and more in the latest Market Talks covering Health Care.

Biocon aims to launch generic copies of the blockbuster weight-loss drug Wegovy in India and Canada within the next two years, a top executive told Reuters, seeking to tap into a market that is ...

More than half of large U.S. employers plan to scale back healthcare benefits next year as rising costs from weight-loss and specialty drugs squeeze budgets, according to a new survey released by ...

China has leveraged its dominance over rare earths for Nvidia chips; however, this expert says world isn't decoupling, it is ...

As the US dollar weakened and central bank policies diverged, Indian investors explored opportunities in Europe, China, and ...

EUROPEAN shares ended lower on Tuesday, dragged down by heavyweight financial and healthcare stocks as investors awaited news ...

Telehealth company Hims & Hers is facing a growing number of U.S. investor lawsuits after Novo Nordisk's decision last month to end a short-lived partnership to sell its Wegovy weight-loss drug ...

Irish Ferries brand owner Irish Continental Group was the strongest performer on the index, closing up 1.44 per cent to €5.64 ...

By Sukriti Gupta, Sanchayaita Roy and Twesha Dikshit (Reuters) -European shares ended lower on Tuesday, dragged down by heavyweight financial and healthcare stocks as investors awaited news on a ...

Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...

STORY: "Absolutely unacceptable and unjustified."That was the reaction from EU ministers to a 30% tariff on European goods ...